FOXO TECHNOLOGIES INC. Stock Issued During Period, Value, Issued for Services
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- FOXO TECHNOLOGIES INC. stock issued during period, value, issued for services for the quarter ending 2024-03-31 was $51.00.
- FOXO TECHNOLOGIES INC. stock issued during period, value, issued for services for the quarter ending 2022-12-31 was $6.69M.
- FOXO TECHNOLOGIES INC. stock issued during period, value, issued for services for the quarter ending 2022-09-30 was -$6.69M.
- FOXO TECHNOLOGIES INC. stock issued during period, value, issued for services for the quarter ending 2022-06-30 was $6.90M.
- FOXO TECHNOLOGIES INC. stock issued during period, value, issued for services for fiscal 2023 was $234.03K, a 96.61% decline from fiscal 2022.
- FOXO TECHNOLOGIES INC. stock issued during period, value, issued for services for fiscal 2022 was $6.90M.
| Period end | Stock Issued During Period, Value, Issued for Services 3 month | Stock Issued During Period, Value, Issued for Services 12 month |
|---|---|---|
| 2024-03-31 | $51.00 10-Q · filed 2025-11-10 | |
| 2023-12-31 | $234.03K 10-K · filed 2025-04-15 | |
| 2022-12-31 | $6.69M derived: 10-K 12 month − 10-Q/A 9 month · filed 2024-06-06 | $6.90M 10-K · filed 2024-06-06 |
| 2022-09-30 | -$6.69M derived: 10-Q/A 9 month − 10-Q 6 month · filed 2024-06-04 | |
| 2022-06-30 | $6.90M 10-Q · filed 2023-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |